Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
US9255142B2 · kind B2 · utility
1Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 9, 2010 |
| Grant date | Feb 9, 2016 |
| Priority date | — |
| Expiry date | Mar 7, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4742
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides uses of cytokeratins as markers for diagnosing epithelium derived cancers. The present invention provides cancer-related epitopes of cytokeratins and monoclonal antibodies which specifically recognize the epitopes. The present invention also provides methods for the early screen, diagnosis or prognosis of epithelium derived cancers in subjects, methods for the evaluation of therapeutic effect of related medicaments or therapies, and kits for accomplishing the methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.